Parvovirus B19 in stem cell transplantation

Paul M Kinsella^{1

2}, Michelle K Yong^{1

3

4}, Monica A Slavin^{1

3

4}, Victoria G Hall^{1

3}

Affiliations

¹ Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
² Department of Infectious Diseases, University of Melbourne, Parkville, Victoria, Australia.
³ Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.
⁴ Department of Infectious Diseases, Royal Melbourne Hospital, Parkville, Victoria, Australia.

Editorial

Paul M Kinsella et al. Transpl Infect Dis. 2023 Oct.

. 2023 Oct;25(5):e14138.

doi: 10.1111/tid.14138. Epub 2023 Aug 23.

Paul M Kinsella^{1

2}, Michelle K Yong^{1

3

4}, Monica A Slavin^{1

3

4}, Victoria G Hall^{1

3}

¹ Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
² Department of Infectious Diseases, University of Melbourne, Parkville, Victoria, Australia.
³ Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.
⁴ Department of Infectious Diseases, Royal Melbourne Hospital, Parkville, Victoria, Australia.

No abstract available

Keywords: hematopoietic cell transplantation; immunocompromised; immunodeficiency; intravenous immunoglobulin; parvovirus B19.

References

1. Servey JT, Reamy BV, Hodge J. Clinical presentations of parvovirus B19 infection. Am Fam Physician. 2007;75(3):373-376.
1. Heegaard ED, Brown KE. Human parvovirus B19. Clin Microbiol Rev. 2002;15(3):485-505.
1. Brown KE. Detection and quantitation of parvovirus B19. J Clin Virol. 2004;31(1):1-4.
1. Sammut R, Feghoul L, Xhaard A, et al. Clinical and immune features of human parvovirus B19 infection in allogeneic stem cell transplantation recipients: a retrospective monocentric study. Transplant Infect Dis. 2023;25:e14118. https://doi.org/10.1111/tid.14118
1. Eid AJ, Brown RA, Patel R, Razonable RR. Parvovirus B19 infection after transplantation: a review of 98 cases. Clin Infect Dis. 2006;43(1):40-48.